Virtus ETF Advisers’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,133
Closed -$63.5K 803
2024
Q4
$63.5K Sell
5,133
-9,089
-64% -$121K 0.03% 431
2024
Q3
$117K Buy
14,222
+252
+2% +$1.51K 0.05% 356
2024
Q2
$69.7K Buy
+13,970
New +$79.7K 0.03% 432
2021
Q4
Sell
-29,090
Closed -$143K 397
2021
Q3
$143K Sell
29,090
-1,510
-5% -$9.15K 0.06% 350
2021
Q2
$204K Sell
30,600
-2,003
-6% -$13.1K 0.08% 331
2021
Q1
$183K Buy
32,603
+571
+2% +$5.49K 0.08% 337
2020
Q4
$252K Buy
32,032
+16
+0% +$134 0.1% 311
2020
Q3
$272K Sell
32,016
-4,345
-12% -$47.6K 0.14% 246
2020
Q2
$379K Buy
36,361
+26,803
+280% +$252K 0.18% 221
2020
Q1
$90K Sell
9,558
-1,390
-13% -$11.8K 0.04% 295
2019
Q4
$88K Buy
10,948
+1,109
+11% +$27.2K 0.01% 292
2019
Q3
$202K Sell
9,839
-548
-5% -$12.6K 0.04% 253
2019
Q2
$271K Buy
10,387
+5,014
+93% +$141K 0.06% 259
2019
Q1
$209K Sell
5,373
-613
-10% -$24.9K 0.44% 87
2018
Q4
$252K Buy
+5,986
New +$266K 0.04% 158

Other funds holding WVE

Virtus ETF Advisers's WVE Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Wave Life Sciences (WVE) in Q1 2025, closing a stake of 5,133 shares — an estimated $63.5K sold.

Virtus ETF Advisers first reported a position in WVE in Q4 2018 and held it in 15 quarters. The position peaked at $379K in Q2 2020. 196 funds tracked by Wall St. Rank hold WVE as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Wave Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 5,133 Wave Life Sciences shares in Q1 2025, an estimated $63.5K.
  • Virtus ETF Advisers first reported a position in Wave Life Sciences in Q4 2018 and held it in 15 quarters.
  • Virtus ETF Advisers's Wave Life Sciences position peaked at $379K in Q2 2020.
  • 196 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.